Rajesh Kumar Radhakrishnan

Dr. Rajesh Kumar Radhakrishnan

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AVAbhinav Vankayalapati
Abhinav Vankayalapati
ODOlamipejo Durojaye
Olamipejo Durojaye
TMTanmoy Mukherjee
Tanmoy Mukherjee
PPPadmaja Paidipally
Padmaja Paidipally
BOBismark Owusu-Afriyie
Bismark Owusu-Afriyie
RRRajesh Kumar Radhakrishnan
Rajesh Kumar Radhakrishnan
Previously, we found that Mycobacterium tuberculosis (Mtb) infection in type 2 diabetes mellitus (T2DM) mice enhances inflammatory cytokine production which drives pathological immune responses and mortality. In the current study, using a T2DM Mtb infection mice model, we determined the mechanisms that make T2DM mice alveolar macrophages (AMs) more inflammatory upon Mtb infection. Among various cell death pathways, necroptosis is a major pathway involved in inflammatory cytokine production by T2DM mice AMs. Anti-TNFR1 antibody treatment of Mtb-infected AMs from T2DM mice significantly reduced expression of receptor interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) (necroptosis markers) and IL-6 production. Metabolic profile comparison of Mtb-infected AMs from T2DM mice and Mtb-infected AMs of nondiabetic control mice indicated that 2-ketohexanoic acid and deoxyadenosine monophosphate were significantly abundant, and acetylcholine and pyridoxine (Vitamin B6) were significantly less abundant in T2DM mice AMs infected with Mtb. 2-Ketohexanoic acid enhanced expression of TNFR1, RIPK3, MLKL and inflammatory cytokine production in the lungs of Mtb-infected nondiabetic mice. In contrast, pyridoxine inhibited RIPK3, MLKL and enhanced expression of Caspase 3 (apoptosis marker) in the lungs of Mtb-infected T2DM mice. Our findings demonstrate that metabolic changes in Mtb-infected T2DM mice enhance TNFR1-mediated necroptosis of AMs, which leads to excess inflammation and lung pathology.

1 April 2021 in Kidney International Reports
Verified
Journal Article
Open access
SUS. Uthup
S. Uthup
APA. Pillai
A. Pillai
BSB. Sarojam
B. Sarojam
GSG. Saradakutty
G. Saradakutty
RRRajesh Kumar Radhakrishnan
Rajesh Kumar Radhakrishnan

9 October 2025 in ImmunoHorizons
Verified
Journal Article
Open access
AVAbhinav Vankayalapati
Abhinav Vankayalapati
BSBharath Somasundram
Bharath Somasundram
PPPadmaja Paidipally
Padmaja Paidipally
KSKaran P Singh
Karan P Singh
RVRamakrishna Vankayalapati
Ramakrishna Vankayalapati
RRRajesh Kumar Radhakrishnan
Rajesh Kumar Radhakrishnan
The IL-1 family of cytokines produced by antigen-presenting cells plays important roles in various diseases and infections, including Mycobacterium tuberculosis (Mtb) infection. In the present study, we infected human monocyte-derived macrophages (MDMs) with Mtb. Then, we measured the production of IL-1 superfamily (ILSF) cytokines (8 soluble factors) and determined the effects of ILSF cytokines on Mtb growth via the use of recombinant cytokines and antibodies. Mtb infection significantly increased the production of IL-1α, IL-1β, IL-18, and IL-37 and reduced the production of IL-1Ra by MDMs. Human recombinant IL-1α, IL-1β, and IL-18 reduced Mtb growth in MDMs. In contrast, human recombinant IL-1Ra enhanced Mtb growth in MDMs. Neutralizing antibodies against IL-1α, IL-1β, and IL-18 enhanced Mtb growth, and neutralizing antibodies against IL-1Ra and IL-33R reduced Mtb growth in MDMs. B cells are known to regulate inflammation in tuberculosis (TB) granulomas. We also determined the effects of B and NK cells on ILSF cytokine production by human monocytes. Furthermore, we determined the effect of B cells on Mtb growth in human monocytes. B cells significantly reduced IL-1α, IL-1β, IL-6, and TNF-α production; enhanced IL-1Ra, IL-18, and IL-10 production; and inhibited Mtb growth in human CD14+ monocytes. These findings may be relevant in human TB granulomas, where B cells may regulate the balance of proinflammatory and anti-inflammatory ILSF cytokines and inhibit TB growth.

28 September 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
NGNandita G
Nandita G
RRRajesh Kumar Radhakrishnan
Rajesh Kumar Radhakrishnan
FSFathima Sumaira
Fathima Sumaira
JVJai Priya Govindasamy Venugopal
Jai Priya Govindasamy Venugopal
BKBhavani P K
Bhavani P K
NKNathella Pavan Kumar
Nathella Pavan Kumar
Background: Type 2 diabetes mellitus (T2DM) increases susceptibility to tuberculosis (TB) and contributes to immune dysregulation, exaggerated inflammation and poor clinical outcomes. Acute-phase proteins (APPs), lung-associated markers (LMs) and TNF superfamily ligands play a crucial role in inflammatory and immune signaling; however, an integrated approach in understanding the inflammatory profile and their immunological association in TB-T2DM remains underexplored. Methods: Plasma levels of APPs and LMs including CRP, SAA1, Haptoglobin, α2M, IDO, CHI3L1, S100A8, S100A9 and granulysin were evaluated for the study cohort of 176 individuals (TB = 44, TB–T2DM = 44, T2DM-only = 44 and healthy-controls = 44). TNF superfamily ligands, including 4-1BBL, APRIL, BAFF, CD30L, CD40L, EDA-1, Fas-L, GITRL, LIGHT, RANKL, NGF- β, TNF-β, TRAIL and TWEAK, were measured using a multiplex immunoassay for 88 individuals (TB = 22, TB–T2DM = 22, T2DM-only = 22 and healthy-controls = 22). Spearman correlation analysis, protein–protein interaction (PPI) network analysis and pathway enrichment analysis were also performed. Results: TB-T2DM individuals exhibited significantly increased inflammatory burden compared with TB, T2DM and HC groups. Increased levels of CRP, SAA1, S100A8, S100A9, haptoglobin, CH3IL1 and α2M were observed (p < 0.05), indicating amplified systemic and pulmonary inflammation. TNF superfamily ligands including BAFF, APRIL, CD40L, GITRL, LIGHT and TRAIL were significantly altered in TB-T2DM individuals, suggesting dysregulated TNF-mediated immune signaling. Correlation analysis revealed strong associations between HbA1c levels and inflammatory markers including BAFF, TRAIL, GITRL, LIGHT, CD40L, APRIL, S100A8 and SAA1 (p < 0.05). Network and enrichment analyses identified significant involvement of cytokine–cytokine receptor interaction, IL-17 signaling, NF-κB signaling, apoptosis and necroptosis pathways. Conclusions: Overall, TB-T2DM comorbidity is characterized by exaggerated inflammatory responses and altered TNF superfamily ligand signaling associated with poor glycemic control. This interconnected immune dysregulation may provide future insights into biomarkers and pathway-related investigation to establish more clinical and biological relevance.